Therapeutic Target Details

Target ID: T30
Target Name: Lysyl oxidase homolog 2
Synonyms: LOXL2; LOXL-2
GENE: LOXL2
Action: antibody
Class: Enzyme
UniProtKB ID:Q9Y4K0
Entry Name: LOXL2_HUMAN
Related Drugs: Simtuzumab
Mechanism: The mechanism entails a cross-talk between enhanced lipotoxicity in insulin resistant HEPs and Loxl2 production by HSCs, which was confirmed in patients with diabetes, thereby facilitating extracellular matrix (ECM) stabilization.
Reference (PMIDs): 28468951

Show More